Quintiles Acquires Outcome Sciences for Late Phase Service Market

Quintiles has acquired Outcome Sciences, Inc., a privately held outcomes research firm headquartered in Cambridge, MA.

US-based biopharmaceutical services company Quintiles has acquired Outcome Sciences, Inc., a privately held outcomes research firm headquartered in Cambridge, MA. The acquisition adds late phase research, offering global reach, dedicated resources and specialization.

Outcome is a provider of observational research services encompassing registries, post-approval research and quality improvement initiatives across biopharmaceutical, medical device, government and providers.

"This acquisition underscores Quintiles’ commitment to delivering efficient, insightful late phase solutions to help customers show the value of their products to patients, providers and payers,” said Quintiles president and chief operating officer, John Ratliff. “The Phase IIIb/IV market is forecast to reac